• Strong pipeline

    Alligator Bioscience has a broad project portfolio with several antibody-based immuno-oncology candidates. The company’s most advanced project, ADC-1013, in clinical Phase I being developed with partner Janssen Biotech, and the preclinical product candidates ATOR-1015, ATOR-1017, och ALG.APV-527.

    Read more